You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ZINECARD Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zinecard, and what generic alternatives are available?

Zinecard is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in ZINECARD is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.

Summary for ZINECARD
Drug patent expirations by year for ZINECARD
Drug Prices for ZINECARD

See drug prices for ZINECARD

Recent Clinical Trials for ZINECARD

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Andrew E. PlacePhase 1
Children's Cancer Research FundPhase 1
University of Colorado, DenverPhase 1

See all ZINECARD clinical trials

US Patents and Regulatory Information for ZINECARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZINECARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ⤷  Try a Trial ⤷  Try a Trial
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ⤷  Try a Trial ⤷  Try a Trial
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ⤷  Try a Trial ⤷  Try a Trial
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ⤷  Try a Trial ⤷  Try a Trial
Pfizer ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZINECARD

See the table below for patents covering ZINECARD around the world.

Country Patent Number Title Estimated Expiration
Sweden 400286 SETT ATT FRAMSTELLA BIS-3,5-DIOXOPIPERAZINER ⤷  Try a Trial
Israel 38342 BIS(3,5-DIXOPIPERAZIN-1-YL)ALKANE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ⤷  Try a Trial
Netherlands 6902744 ⤷  Try a Trial
France 2154389 ⤷  Try a Trial
United Kingdom 1374979 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.